JP2022545682A5 - - Google Patents
Info
- Publication number
- JP2022545682A5 JP2022545682A5 JP2022512306A JP2022512306A JP2022545682A5 JP 2022545682 A5 JP2022545682 A5 JP 2022545682A5 JP 2022512306 A JP2022512306 A JP 2022512306A JP 2022512306 A JP2022512306 A JP 2022512306A JP 2022545682 A5 JP2022545682 A5 JP 2022545682A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- igm
- variant
- motif
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962891263P | 2019-08-23 | 2019-08-23 | |
| US62/891,263 | 2019-08-23 | ||
| PCT/US2020/047495 WO2021041250A1 (en) | 2019-08-23 | 2020-08-21 | Igm glycovariants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545682A JP2022545682A (ja) | 2022-10-28 |
| JP2022545682A5 true JP2022545682A5 (enExample) | 2023-08-16 |
Family
ID=74684266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512306A Ceased JP2022545682A (ja) | 2019-08-23 | 2020-08-21 | ＩｇＭグリコバリアント |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220306760A1 (enExample) |
| EP (1) | EP4017533A4 (enExample) |
| JP (1) | JP2022545682A (enExample) |
| KR (1) | KR20220050166A (enExample) |
| CN (1) | CN114269380A (enExample) |
| AU (1) | AU2020337333A1 (enExample) |
| BR (1) | BR112022003282A2 (enExample) |
| CA (1) | CA3149350A1 (enExample) |
| IL (1) | IL290253A (enExample) |
| MX (1) | MX2022002239A (enExample) |
| WO (1) | WO2021041250A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4011910A1 (en) | 2014-04-03 | 2022-06-15 | IGM Biosciences, Inc. | Modified j-chain |
| PT3247728T (pt) | 2015-01-20 | 2020-07-16 | Igm Biosciences Inc | Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas |
| WO2016154593A1 (en) | 2015-03-25 | 2016-09-29 | Igm Biosciences, Inc. | Multi-valent hepatitis b virus antigen binding molecules and uses thereof |
| ES2819870T3 (es) | 2015-09-30 | 2021-04-19 | Igm Biosciences Inc | Moléculas de unión con cadena J modificada |
| PT3355913T (pt) | 2015-09-30 | 2024-12-18 | Igm Biosciences Inc | Moléculas de ligação com cadeia j modificada |
| CN111787951B (zh) | 2018-03-01 | 2025-06-17 | Igm生物科学股份有限公司 | 影响IgM血清半衰期的IgM Fc和J链突变 |
| KR20220035369A (ko) | 2019-06-07 | 2022-03-22 | 아디맵 엘엘씨 | 고 친화도 항-cd3 항체, 및 이의 생성 및 사용 방법 |
| CA3231006A1 (en) * | 2021-09-17 | 2023-03-23 | Adimab, Llc | Anti-cd3 antibodies |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0809042B1 (pt) * | 2007-03-22 | 2021-08-31 | Biogen Ma Inc. | Proteína de ligação a cd154 isolada, seu uso, e composição |
| CA2780221A1 (en) * | 2009-11-04 | 2011-05-12 | Fabrus Llc | Methods for affinity maturation-based antibody optimization |
| EP4011910A1 (en) * | 2014-04-03 | 2022-06-15 | IGM Biosciences, Inc. | Modified j-chain |
| PT3355913T (pt) * | 2015-09-30 | 2024-12-18 | Igm Biosciences Inc | Moléculas de ligação com cadeia j modificada |
| WO2017106462A1 (en) * | 2015-12-18 | 2017-06-22 | Biogen Ma Inc. | Bispecific antibody platform |
| EP3571222A4 (en) * | 2017-01-19 | 2021-06-16 | Cedars-Sinai Medical Center | METHOD BASED ON HIGHLY MULTIPLEX AND MASS SPECTROMETRY FOR MEASURING HUMAN 72 PROTEINS |
| EP3600442A1 (en) * | 2017-03-22 | 2020-02-05 | Genentech, Inc. | Optimized antibody compositions for treatment of ocular disorders |
| CN111417651B (zh) * | 2017-12-01 | 2023-09-29 | 诺华股份有限公司 | 多瘤病毒中和抗体 |
-
2020
- 2020-08-21 MX MX2022002239A patent/MX2022002239A/es unknown
- 2020-08-21 EP EP20859308.7A patent/EP4017533A4/en not_active Withdrawn
- 2020-08-21 JP JP2022512306A patent/JP2022545682A/ja not_active Ceased
- 2020-08-21 US US17/637,349 patent/US20220306760A1/en not_active Abandoned
- 2020-08-21 CA CA3149350A patent/CA3149350A1/en active Pending
- 2020-08-21 BR BR112022003282A patent/BR112022003282A2/pt unknown
- 2020-08-21 CN CN202080059541.5A patent/CN114269380A/zh active Pending
- 2020-08-21 AU AU2020337333A patent/AU2020337333A1/en not_active Abandoned
- 2020-08-21 WO PCT/US2020/047495 patent/WO2021041250A1/en not_active Ceased
- 2020-08-21 KR KR1020227008888A patent/KR20220050166A/ko not_active Ceased
-
2022
- 2022-01-31 IL IL290253A patent/IL290253A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7788113B2 (ja) | Ｃｈ３ドメインに基づくヘテロダイマー分子、その調製方法及び用途 | |
| ES3031036T3 (en) | Ch3 modified igg bispecific antibodies and processes for preparation | |
| ES2821753T3 (es) | Procedimientos de producción de Fab y de anticuerpos biespecíficos | |
| TWI359028B (en) | Bivalent, bispecific antibodies | |
| ES2469791T3 (es) | Anticuerpos biespec�ficos bivalentes | |
| JP6247673B2 (ja) | 天然の免疫グロブリン形式を有する容易に単離される二重特異性抗体 | |
| CN108601830B (zh) | 双特异性抗体平台 | |
| EP3487532A1 (en) | Modified antigen-binding fab fragments and antigen-binding molecules comprising the same | |
| KR102247704B1 (ko) | 항 pd-1/항 her2 천연항체 구조 형태의 헤테로다이머 계의 이중특이성 항체 및 그 제조방법 | |
| JP2020514277A5 (enExample) | ||
| JP2024546763A5 (enExample) | ||
| JP2024546759A5 (enExample) | ||
| WO2021228091A1 (zh) | St2抗原结合蛋白 | |
| JP2024520577A (ja) | 抗ｎｋｇ２ａ抗体及び組成物 | |
| JP2024516098A5 (enExample) | ||
| JP2023076596A (ja) | ＴＧＦ－βＲＩＩ結合タンパク質 | |
| WO2022166977A1 (zh) | 抗人il-36r抗体及其应用 | |
| CN116867514A (zh) | 用于异二聚化的正交突变 | |
| TWI857999B (zh) | 截斷的多價多元體 | |
| WO2022148412A1 (zh) | 特异性结合cd47的抗体及其抗原结合片段 | |
| JP2022517549A (ja) | 二価の二重特異性抗体およびその製造方法、コードする遺伝子、宿主細胞、組成物 | |
| ES3040852T3 (en) | Engineering charge pair mutations for pairing of hetero-igg molecules | |
| CN119546637A (zh) | 与FCγ受体的结合降低的嵌合重链恒定结构域及其用途 | |
| US20260098094A1 (en) | Cµ4 REGION FOR PAIRING HEAVY AND LIGHT CHAINS IN MULTI-SPECIFIC ANTIBODIES | |
| JP7498747B2 (ja) | 抗ｇｍ２ａｐ抗体及びその応用 |